Sumitomo Mitsui Trust Holdings, Inc. Ionis Pharmaceuticals Inc Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $145 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 156,657 shares of IONS stock, worth $5.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156,657
Previous 196,114
20.12%
Holding current value
$5.23 Million
Previous $7.86 Million
30.3%
% of portfolio
0.0%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$550 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$473 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$383 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$345 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$290 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.74B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...